期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

炎症性肠病与骨质疏松 被引量：1

下载PDF
导出
摘要 炎症性肠病（inflammatory bowel disease，IBD）是以反复发作的慢性肠道炎症为特点的一组疾病，主要包括溃疡性结肠炎（ulcerative colitis，UC）和克罗恩病（Crohndisease，CD），同时伴有多种肠道外表现。骨质疏松症是一种以骨量低下、骨微结构破坏、骨脆性增加、易发生骨折为特征的全身性骨病，同时也是IBD严重却又易被忽视的并发症之一。
作者 李攀 钱家鸣
机构地区 中国医学科学院北京协和医学院北京协和医院消化内科
出处 《协和医学杂志》 2010年第2期191-195,共5页 Medical Journal of Peking Union Medical College Hospital
关键词 炎症性肠病 骨质疏松
分类号 R574 [医药卫生—消化系统] R589.5 [医药卫生—内分泌]
  • 相关文献

参考文献34

  • 1罗林枝,徐苓.维生素K与骨质疏松[J].中国医学科学院学报,2003,25(3):346-349. 被引量：7
  • 2Genant HK,,Mall JC,Wagonfeld JB,et al.Skeletal demi-neralization and growth retardation in inflammatory bowel dis-ease. Investigative Radiology . 1976
  • 3Pollak RD,Karmeli F,Eliakim R,et al.Femoral neck os-teopenia in patients with inflammatory bowel disease. The American journal of Gastroenterology . 1998
  • 4Card T,WestJ,Hubbard R,etal.Hip fractures in patients with inflammatory bowel disease and their relationship to cor-ticosteroid use:a population based cohort study. Gut . 2004
  • 5Van Staa TP,Leufkens HG,CooperC.The epidemiolo-gy of corticosteroid-induced osteoporosis:a meta-analysis. Osteoporosis International . 2002
  • 6Schulte CM,Dignass AU,Goebell H,et al.Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology . 2000
  • 7Boyce BF,Xing L.The RANKL/RANK/OPG pathway. Curr Osteoporos Rep . 2007
  • 8Bernstein CN,Sargent M,Leslie WD.Serum osteopro-tegerin is increased in Crohn s disease:a population-based case control study. Inflammatory Bowel Diseases . 2005
  • 9Moschen AR,Kaser A,Enrich B,et al.The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut . 2005
  • 10Miheller P,Muzes G,Racz K,et al.Changes of OPG and RANKL concentrations in Crohn s disease after infliximab therapy. Inflammatory Bowel Diseases . 2007

二级参考文献31

  • 1赵新华,赵熙和,崔伟,任典旭.维生素K对幼鼠骨量及骨强度影响的实验研究[J].中国骨质疏松杂志,1999,5(1):22-27. 被引量：5
  • 2郭世拔 罗先正 邱贵兴.骨质疏松基础与临床[M].天津：科学技术出版社,2001.522-531.
  • 3Takahashi M, Naitou K, Ohishi T. et al. Effect of vitamin K and/or D on undercarboxylated and intact osteocalein in osteoporofic patients with vertebral or hip fractures. Clin Endocrinol, 2001, 54(2):219-224.
  • 4Kon-Siong GJ, Hamulyak K, Gijsbers BL, et al. Effects of vitamin K and oral anticoagulants on urinary calcium excretion. Br J Haematol, 1993, 83:100-104.
  • 5Scholz-Aluens KE, Bohme P, Schrezenmeir J, et al. Vitamin K deficiency affects calcium retention, bone mineralization and Apb in growing and ovarieetomized rats. Osteoporosis Int, 1996, 6:S141.
  • 6Binldey NC, Suttie JW. Vitamin K Nutrition and Osteoporosis. J Nutr, 1995, 125:1812-1821.
  • 7Reddi K, Henderson B, Meghji S, et al.Interleukin 6 production by lipopolysaecharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine, 1995, 7:287-290.
  • 8Miyaura C, Kasano K, MasuzawaT, et al. Endogenous boneresorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res, 1995, 10.1365-1373.
  • 9Hart JP, Shearer MJ, Klenerman L, et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporoais. J Clin Endecrinol Metab, 1985, 60:1268-1269.
  • 10Booth SL, Broe KE, Mclean RR, et al. Low vitamin K status is associated with low bone mineral density and quantitative ultrasound in men. 24th Annual Meeting of the American Society for Bone and Mineral Research, 2002. 234.

共引文献6

同被引文献6

引证文献1

二级引证文献1

协和医学杂志
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部